In preparation for a new wave of products to hit dispensary shelves later this year, two B.C. companies teamed up to produce a line of cannabis extracts for the legal Canadian market.
Multi-licensed extraction company Valens GroWorks announced today (May 28) the signing of a two-year service agreement with federally licensed cannabis producer Tantalus Labs.
Using its proprietary methodologies, equipment, and facilities, Valens will process “exclusive phenotypes” grown in Tantalus’ SunLab to deliver a line of “premium quality resins and distillates.”
“Tantalus aspires to deliver unprecedented vaporization experiences to a discerning user base,” said Dan Sutton, CEO of Tantalus Labs in a release.
Related Post
“Valens is absolutely our best in breed partner to formulate these experiences with.”
“We are honored to be recognized by Tantalus, one of the industry’s most respected players currently providing exceptional flower products to both medical and recreational users here in Canada,” said Tyler Robson, CEO of Valens GroWorks in the same release.
“We look forward to working closely with the team at Tantalus as they broaden their product portfolio under the anticipated new regulations this fall.”
Last year, Health Canada legalized five classes of cannabis products for sale through approved retail channels: fresh and dried cannabis, seeds, infused oils, and plants. The federal regulator has set October 17, 2019 as the date for the next wave of product classes to enter the market, which include infused topicals, edibles, and extracts.
